Download the Protocol

NAD+

NAD+ is a molecule found in every cell that helps convert food into energy. It supports DNA repair, healthy aging, and cell recovery. Levels of NAD+ naturally decline with age, which may reduce energy and slow metabolism. Restoring NAD+ is being studied as a way to boost vitality and support cellular health, but human research is still developing.

Description

• Nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme found in all living cells.
• Functions as a key regulator of cellular energy metabolism, redox balance, and DNA repair.
• Levels decline with age, leading to reduced mitochondrial efficiency and metabolic slowdown.

How It Works

• Serves as an electron carrier in mitochondrial ATP production (oxidative phosphorylation).
• Activates sirtuins (SIRT1–SIRT7) and PARP enzymes involved in DNA repair and longevity pathways.
• Supports metabolic homeostasis by regulating energy and stress responses at the cellular level.

Documented Effects

• Enhances mitochondrial function and cellular resilience in preclinical and clinical studies.
• Improves recovery, alertness, and cognitive clarity in NAD+ infusion studies.
• May support DNA repair and cellular detoxification during oxidative stress.
• Used in research for aging, neurodegeneration, and metabolic support protocols.

Theoretical Effects

• May slow biological aging by restoring mitochondrial NAD+ pools.
• Potential synergistic benefit when paired with NMN or NR precursors to sustain intracellular NAD+ levels.
• No conclusive long-term human data confirming anti-aging claims.

Pharmacokinetics

• Half-life: 1–4 hours (rapid cellular uptake and metabolism).
• Peak activity: Within 1 hour post IV or IM administration.
• Bioavailability: Moderate via injection; minimal via oral form due to poor absorption.

Reconstitution

• Use only bacteriostatic water or sterile saline to mix the lyophilized powder.
• Example vial: 500 mg of NAD+
• Choose reconstitution volume based on dosing convenience:
  • 1 mL water → 500 mg/mL → 50 mg per 10 units
  • 2 mL water → 250 mg/mL → 25 mg per 10 units
  • 10 mL water → 50 mg/mL → 5 mg per 10 units
• Swirl gently to dissolve; avoid shaking.
• Refrigerate reconstituted solution (2–8 °C). Use within ~7 days for best stability.

Injectable Dosage Overview (Research Reference)

Typical Starting Dose

• Injectable (off-label, research): ~100–250 mg subcutaneous (SC) or intramuscular (IM) per session.
• Conservative entry point: 100 mg twice weekly to assess tolerance.

Common Research Range

• Typical range: 250–500 mg per injection, 2–3 times per week.
• IV infusions in research protocols use 250–1000 mg per session for systemic NAD+ replenishment.

Maximum Weekly Dose

• Anecdotal ceiling: 1000–1500 mg per week divided into several doses.
• Higher single-session IV doses can cause temporary flushing or pressure sensations.

Standard Cycle Length

• Common research cycles: 4–8 weeks continuous administration.
• Maintenance protocols: once weekly or biweekly injections for ongoing energy and recovery support.

Clinical Notes

• Administer slowly if IV to prevent discomfort or flushing.
• Combining with NMN or NR precursors may extend benefits by maintaining NAD+ turnover.
• Monitor hydration and electrolyte balance during IV administration.
• Stable for about 7 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing./li>

Safety Notes

• Begin with lower doses to minimize transient flushing or mild nausea.
• Possible effects: warmth, light-headedness, temporary fatigue during or after administration.
• Maintain sterile technique; confirm compound authenticity and purity.
• No long-term adverse events established in controlled human trials at physiological replacement doses.